Change Path »

Adma Biologics shares owned by Change Path

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Change Path from 13F filings

Historical chart of Change Path investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Change Path consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Change Path

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 127k 8.37

More positions owned by Change Path

Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (SPYM)
Pimco Etf Tr Active Bd Etf (BOND)
Advisorshares Tr Star Glob Buyw (VEGA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Blackrock Etf Trust Ishares Intl Ctr (CORO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)

View all positions for Change Path

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
Rubric Capital Management
Capital Research Global Investors
First Trust Advisors
Geode Capital Management
Caligan Partners
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Nuveen
Duquesne Family Office
Morgan Stanley

View all funds holding Adma Biologics